Difference between revisions of "Team:UiOslo Norway"
Markushovd (Talk | contribs) |
Markushovd (Talk | contribs) |
||
| Line 10: | Line 10: | ||
width: 60%; | width: 60%; | ||
margin-top: 10px; | margin-top: 10px; | ||
| + | } | ||
| + | |||
| + | .goldborder { | ||
| + | border: 2px solid gold; | ||
} | } | ||
| Line 26: | Line 30: | ||
<h3 style="text-align: center;">UiOslo_Norway</h3> | <h3 style="text-align: center;">UiOslo_Norway</h3> | ||
| − | <h3 style="text-align:center; text-decoration: italic | + | <h3 class="goldborder" style="text-align:center; text-decoration: italic;">Awarded Best Diagnostic Project</br>Nominated Best Presentation</h3> |
Revision as of 12:36, 7 November 2018
Fast detection of vulvovaginal Candida albicans infections using CRISPR/dCas9
UiOslo_Norway
Awarded Best Diagnostic ProjectNominated Best Presentation
During their lifetime 75% of women will experience a Candida albicans infection, one of the most common vulvovaginal yeast infections. Currently there are no fast methods to detect whether an infection is caused by C. albicans. As a result, women purchase over-the-counter antimycotics without knowing the cause of their infection. This contributes to the rise of antimycotic resistance, making treatment of future infections more difficult.
Based on previous projects, UiOslo_Norway aims to develop a fast detection kit for C. albicans infections, using CRISPR/dCas9. Upon a suspected infection, a vaginal sample will be treated with glucanase to selectively lyse yeast cells walls, exposing the fungal DNA. Afterwards, modified dCas9 enzymes fused with split β-lactamase are added. Using specifically designed guideRNAs, the dCas9 complexes bind adjacently on C. albicans specific DNA sequences. This activates the β-lactamase to cleave its substrate nitrocefin, producing a colored product indicating the presence of C. albicans DNA.
Contact information: uioslonorway (at) gmail dot com